Get Your Personalized Supplement StackSupplement Stack Quiz

Lily Of The Valley Root Extract

Also known as: Lily of the Valley, May lily, Lily of the Valley Root Extract, Convallaria majalis

Overview

Convallaria majalis, commonly known as Lily of the Valley, is a perennial flowering plant traditionally utilized in herbal medicine, primarily for its cardiovascular effects. The root extract is rich in cardiac glycosides, particularly convallatoxin, along with flavonoids and phenolic compounds. Its main application is for its cardiotonic properties, which include addressing arrhythmias, tachycardia, and symptoms associated with mitral valve prolapse. Additionally, it has been noted for its anti-inflammatory and diuretic actions. While it has a history of use and is supported by some preclinical and clinical studies, large-scale, high-quality randomized controlled trials (RCTs) specifically on this extract are limited. Most available data stem from smaller studies, herbal combination research, or preclinical models, indicating a moderate but not extensively robust research foundation. Due to its potent compounds, it possesses a narrow therapeutic window, necessitating careful use.

Benefits

Lily of the Valley root extract offers several potential benefits, primarily centered around its cardiovascular effects. It exhibits cardiotonic properties, similar to digitalis glycosides, by enhancing heart muscle contractility and regulating rhythm. It has been used as an adjunctive or standalone treatment for conditions like tachycardia, arrhythmias, and mitral valve prolapse, with reported symptomatic improvements. The strength of evidence for these cardiac benefits is moderate, largely based on historical use and smaller clinical observations rather than large-scale RCTs. Beyond cardiovascular support, the extract demonstrates anti-inflammatory effects. Its cardiac glycosides, such as convallatoxin, are known to inhibit pro-inflammatory cytokines (e.g., TNF-α, IL-1β) and suppress the NF-κB pathway, suggesting a role in reducing chronic inflammation. Some evidence also points to diuretic and mild anti-epileptic properties, though these are less thoroughly researched. Benefits are most relevant for cardiac patients experiencing arrhythmias or mild heart failure symptoms. Quantitative effect sizes are rarely reported, and most findings are qualitative or from small cohorts. Clinical improvements in cardiac symptoms have been observed within weeks of administration.

How it works

The primary mechanism of action for Convallaria majalis root extract lies with its active compounds, cardiac glycosides like convallatoxin. These compounds work by inhibiting the Na⁺/K⁺-ATPase pump within cardiac muscle cells. This inhibition leads to an increase in intracellular calcium levels, which in turn enhances myocardial contractility, improving the heart's pumping efficiency. The anti-inflammatory effects are mediated through the inhibition of NF-κB signaling and a reduction in the production of pro-inflammatory cytokines. Additionally, flavonoids and phenolic compounds present in the extract contribute antioxidant effects, helping to reduce oxidative stress within cardiovascular tissues. While the exact bioavailability is not fully characterized, these glycosides are generally absorbed orally, though their metabolism can vary.

Side effects

Lily of the Valley root extract has a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is small, similar to other cardiac glycosides. Common side effects, occurring in over 5% of users, can include gastrointestinal upset, dizziness, and cardiac arrhythmias, particularly if the dosage is not carefully managed. Less common side effects (1-5%) may involve allergic reactions and mild hypotension. Rare but severe side effects (less than 1%) include significant cardiac toxicity and symptoms resembling digitalis poisoning. A critical concern is its interaction with other medications, especially digoxin and other cardiac glycosides, as co-administration can significantly increase the risk of toxicity. The extract is contraindicated during pregnancy and breastfeeding due to potential toxicity risks. It should also be avoided by individuals with known hypersensitivity to digitalis or severe cardiac conduction disorders. Caution is advised for children and the elderly due to their increased susceptibility to toxicity.

Dosage

Typical dosages of Lily of the Valley root extract, as observed in studies, range from 100 to 400 mg per day of the standardized extract. This often corresponds to approximately 0.4 mg of convallatoxin administered twice daily. It is crucial to note that there is no established maximum safe dose for this extract, and dosing must be highly individualized and closely monitored by a healthcare professional due to its narrow therapeutic window and potential for toxicity. The extract is usually administered orally in divided doses. While specific data on how food affects absorption are limited, it is generally taken with or without food. No specific cofactors are identified as necessary for its efficacy. During its use, regular monitoring of electrolytes and cardiac function is strongly advised to ensure safety and prevent adverse effects.

FAQs

Is Lily of the Valley root extract safe?

It can be safe at therapeutic doses but has a narrow safety margin. There is a potential for serious cardiac toxicity, especially if combined with digoxin or taken in overdose, requiring careful medical supervision.

How quickly does it work?

The cardiac effects of Lily of the Valley root extract may become noticeable within days to a few weeks of consistent administration, depending on the individual and condition being addressed.

Can it be used during pregnancy?

No, Lily of the Valley root extract is contraindicated during pregnancy due to its potential for toxicity, which could pose risks to both the mother and the developing fetus.

Does it interact with other heart medications?

Yes, it has significant interactions, particularly with digoxin and other cardiac glycosides. Co-administration can increase the risk of toxicity and should be avoided or managed with extreme caution under medical guidance.

Research Sources

https://restorativemedicine.org/wp-content/uploads/2012/09/The-Use-of-Convallaria-and-Crataegus-in-the-Treatment-of-Cardiac-Dysfunction.pdf – This review, which includes clinical data, suggests that Convallaria root extract (100-400 mg/day) may offer benefits for tachycardia and arrhythmias. However, it strongly cautions about potential interactions with digoxin, highlighting the need for careful use due to limited high-quality randomized controlled trial data and its primary use as an adjunctive treatment.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11085323/ – This pharmacological review details the mechanisms of action for cardiac glycosides, including their anti-inflammatory effects. It explores the potential for treating chronic inflammation, providing mechanistic insights but primarily relying on preclinical and mechanistic studies rather than clinical trials.
https://www.ijpsjournal.com/article/Pharmacological+Insights+into+Convallaria+Majalis+Lily+of+The+Valley+From+Traditional+Uses+to+Scientific+Validation – This article provides pharmacological insights into Convallaria majalis, bridging its traditional uses with scientific validation. It discusses the plant's active compounds and their potential therapeutic applications, contributing to the understanding of its properties from a scientific perspective.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11337612/ – This systematic review examines various herbal interventions for cardiovascular diseases, mentioning Convallaria as one of the herbs with potential cardiovascular benefits. However, it notes the lack of isolated randomized controlled trials specifically on Convallaria and highlights the heterogeneous nature of the available data, indicating a need for more focused research.